Abstract
To undertake a cost-effectiveness analysis of using microarray comparative genomic hybridisation (array-CGH) as a first-line test versus as a second-line test for the diagnosis of causal chromosomal abnormalities in patients referred to a NHS clinical genetics service in the UK with idiopathic learning disability, developmental delay and/or congenital anomalies.
| Original language | English |
|---|---|
| Pages (from-to) | 421-432 |
| Number of pages | 12 |
| Journal | Applied Health Economics and Health Policy |
| Volume | 13 |
| Issue number | 4 |
| Early online date | 19 Apr 2015 |
| DOIs | |
| Publication status | Published - Aug 2015 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver